Loading…
Reported covered position: U.S. House Cong. Drew Ferguson-LA, LD, D.CoS (1/2017-5/2024); U.S.Senate office of Johnny Isakson: Staff Asst, LC (9/2014-1/2017)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Discussions on payment acceptance Discussions in support of the Credit Card Competition Act Discussions related to the Common Cents Act, H.R.3074, regarding federal guidance on rounding payments in cash transactions
Ensuring Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.3164/S.2426, Main Street Pharmacy Access Act Discussions related to S.2355, the Patients Deserve Price Tags Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2026 · third_quarter · Q3
Discussions regarding H.R.3164/S.2426, Main Street Pharmacy Access Act Discussions related to S.2355, the Patients Deserve Price Tags Act Discussions related to Walmart's health and wellness business and priorities Discussions regarding employee benefits innovations
Discussions related to corporate tax rate, tax incentives and revenue measures Discussions regarding international taxation: implementation of the OECD/G20 Inclusive Framework agreement and Digital Services Taxes
Source: Senate LDA
Ensuring Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.3164/S.2426, Main Street Pharmacy Access Act Discussions related to S.2355, the Patients Deserve Price Tags Act Discussions related to Walmart's health and wellness business and priorities Discussions regarding employee benefits innovations
Ensuring Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.3164/S.2426, Ensuring/Equitable Community Access to Pharmacist Services Act (ECAPS) Discussions related to drug prices
Discussions regarding pricing and digital shelf labels Discussions regarding S3892/H.R.4966, the Stop Price Gouging in Grocery Stores Act Discussions related to on-line marketplace compliance programs Discussions related to federal privacy legislation
Discussions regarding company investment in associates including opportunity, workforce training initiatives, wages, benefits and future of work Discussions related to H.R.5408, Faster Labor Contracts Act
Discussions regarding H.R.3164/S.2426, Main Street Pharmacy Access Act Discussions related to S.2355, the Patients Deserve Price Tags Act
Discussions regarding H.R.3164/S.2426, Main Street Pharmacy Access Act Discussions related to S.2355, the Patients Deserve Price Tags Act Discussions related to Walmart's health and wellness business and priorities Discussions regarding employee benefits innovations
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.3164/S.2426, Main Street Pharmacy Access Act Discussions related to S.2355, the Patients Deserve Price Tags Act
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.3164/S.2426, Main Street Pharmacy Access Act Discussions related to S.2355, the Patients Deserve Price Tags Act Discussions related to Walmart's health and wellness business and priorities Discussions regarding employee benefits innovations
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC · Firm: WALMART INC.
Discussions regarding H.R.3164/S.2426, Ensuring/Equitable Community Access to Pharmacist Services Act (ECAPS) Discussions related to drug prices
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions regarding implementation of USMCA Discussions regarding S.3841, Last Sale Valuation Act of 2026 Discussions regarding Securing Accountability in Foreign Entries (SAFE) Act Discussions regarding trade preference programs Discussions regarding the African Growth and Opportunity Act (AGOA) Discussions related to market operations and opportunities in ongoing trade negotiations
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions regarding implementation of USMCA Discussions regarding S.3841, Last Sale Valuation Act of 2026
Discussions regarding pricing and digital shelf labels Discussions regarding S3892/H.R.4966, the Stop Price Gouging in Grocery Stores Act Discussions related to on-line marketplace compliance programs Discussions related to federal privacy legislation
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: WALMART INC · Firm: WALMART INC.
Discussions related to corporate tax rate, tax credits and revenue measures, H.R.1, One Big Beautiful Bill Act (2025) Discussions regarding international taxation: OECD Pillar II Model rules
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: WALMART INC · Firm: WALMART INC.
Discussions related to corporate tax rate, tax credits and revenue measures, H.R.1, One Big Beautiful Bill Act (2025) Discussions regarding international taxation: OECD Pillar II Model rules Discussions regarding the Work Opportunity Tax Credit
Discussions regarding pricing and digital shelf labels Discussions regarding S3892/H.R.4966, the Stop Price Gouging in Grocery Stores Act Discussions related to on-line marketplace compliance programs Discussions related to federal privacy legislation
Discussions regarding U.S. manufacturing commitment and supply chain policy
Discussions regarding company investment in associates including opportunity, workforce training initiatives, wages, benefits and future of work Discussions related to H.R.5408, Faster Labor Contracts Act
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
2026 · second_quarter · Q2
Discussions related to electricity transmission, tax incentives, autonomous vehicles, electric vehicles and transportation
Discussions in support of the Combating Organized Retail Crime Act
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions regarding implementation of USMCA Discussions regarding S.3841, Last Sale Valuation Act of 2026
Discussions related to corporate tax rate, tax incentives and revenue measures Discussions regarding international taxation: implementation of the OECD/G20 Inclusive Framework agreement and Digital Services Taxes
Discussions regarding U.S. manufacturing commitment and supply chain policy
Discussions on payment acceptance Discussions in support of the Credit Card Competition Act Discussions related to the Common Cents Act, H.R.3074, regarding federal guidance on rounding payments in cash transactions
Discussions regarding H.R.3164/S.2426, Main Street Pharmacy Access Act Discussions related to S.2355, the Patients Deserve Price Tags Act
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2026 · first_quarter · Q1
Discussions regarding H.R.3164/S.2426, Ensuring/Equitable Community Access to Pharmacist Services Act (ECAPS) Discussions related to drug prices
Discussions regarding company investment in associates including opportunity, workforce training initiatives, wages, benefits and future of work
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions regarding implementation of USMCA Discussions regarding S.3841, Last Sale Valuation Act of 2026 Discussions regarding Securing Accountability in Foreign Entries (SAFE) Act Discussions regarding trade preference programs Discussions regarding the African Growth and Opportunity Act (AGOA) Discussions related to market operations and opportunities in ongoing trade negotiations
Discussions related to corporate tax rate, tax credits and revenue measures Discussions regarding international taxation: OECD Pillar II Model rules
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2025 · fourth_quarter · Q4
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions regarding implementation of USMCA Discussions related to India and Trade
Discussions regarding company investment in associates including opportunity, workforce training initiatives, wages, benefits and future of work
Discussions related to Civil Litigation Transparency
Discussions regarding U.S. manufacturing commitment and supply chain policy
Discussions related to corporate tax rate, tax credits and revenue measures Discussions regarding international taxation: OECD Pillar II Model rules Discussions regarding extension of the work opportunity tax credit, workforce training initiatives, and opportunity programs that benefit the future of work
Discussions in support of the Combating Organized Retail Crime Act
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Science & Technology Policy (OSTP), SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2025 · third_quarter · Q3
Discussions regarding company investment in associates including opportunity, workforce training initiatives, wages, benefits and future of work
Discussions regarding trade enforcement actions and tariff proposals by the Administration
Discussions regarding U.S. manufacturing commitment and supply chain policy
Discussions related to corporate tax rate, tax credits and revenue measures, H.R.1, One Big Beautiful Bill Act (2025) Discussions regarding international taxation: OECD Pillar II Model rules Discussions regarding the Work Opportunity Tax Credit
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Executive Office of the President (EOP), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Maritime Administration (MARAD), Natl Economic Council (NEC), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2025 · second_quarter · Q2
Discussions regarding U.S. manufacturing commitment and supply chain policy
Discussions related to corporate tax rate, tax credits and revenue measures, H.R.1, One Big Beautiful Bill Act (2025) Discussions regarding international taxation: OECD Pillar II Model rules
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Education, Dept of, Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Intl Trade Administration (ITA), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2025 · first_quarter · Q1
Discussions related to corporate tax rate and revenue measures Discussions regarding international taxation: OECD Pillar II Model rules Discussions regarding tax extenders
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2024 · fourth_quarter · Q4
Discussions related to corporate tax rate and revenue measures
Discussions regarding U.S. manufacturing commitment and supply chain policy
Discussions regarding trade enforcement actions and tariff proposals Discussion of trade preference programs
Filing targets: Agriculture, Dept of (USDA), Education, Dept of, Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Economic Council (NEC), SENATE, White House Office
2024 · third_quarter · Q3
Discussions regarding company investment in associates including opportunity, workforce training initiatives, wages, benefits and future of work
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussion of trade preference programs
Discussions related to corporate tax rate and revenue measures
Filing targets: Administration for Children & Families (ACF), Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Federal Aviation Administration (FAA), Federal Maritime Commission, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Economic Council (NEC), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), White House Office
2024 · second_quarter · Q2
Discussions regarding international taxation: OECD Pillar II Model Rules Discussions related to corporate tax rate and revenue measures
Discussions regarding trade enforcement actions and tariff proposals by the Administration Discussions related to renegotiation of the North American Free Trade Agreement (NAFTA) Discussions regarding fresh fruit and vegetable trade
Discussions regarding U.S. manufacturing commitment and supply chain policy
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office